Chemed Corporation
CHENYSEHealthcare● Active
$441.59
+$9.25(+2.14%)
Market Cap$5.9B
P/E Ratio—
52W High$565.66
52W Low$365.21
Chemed Corporation (CHE) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CHE · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $2.53B | $2.43B | $2.26B | $2.13B | $2.14B |
| Cost of Revenue | $1.77B | $1.58B | $1.47B | $1.37B | $1.37B |
| Gross Profit | $0.76B | $0.85B | $0.80B | $0.77B | $0.77B |
| Gross Margin %(computed) | 29.97% | 35.14% | 35.28% | 35.84% | 35.98% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.42B | $0.40B | $0.36B | $0.37B |
| Total Operating Expenses | $0.42B | $0.49B | $0.46B | $0.42B | $0.43B |
| Operating Income | $0.34B | $0.37B | $0.34B | $0.34B | $0.34B |
| Operating Margin %(computed) | 13.37% | 15.07% | 15.04% | 16.09% | 16.04% |
| Interest Income | $0.01B | $0.01B | $0.01B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | $0.36B | $0.40B | $0.35B | $0.33B | $0.35B |
| Income Tax Expense | $0.09B | $0.10B | $0.08B | $0.08B | $0.08B |
| Net Income | $0.27B | $0.30B | $0.27B | $0.25B | $0.27B |
| Net Margin %(computed) | 10.48% | 12.42% | 12.03% | 11.69% | 12.55% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $18.42 | $20.10 | $18.11 | $16.72 | $17.14 |
| Wtd Avg Shares | 0.01B | 0.02B | 0.02B | 0.01B | 0.02B |
| EBITDA | $0.42B | $0.46B | $0.41B | $0.39B | $0.41B |
| EBITDA Margin %(computed) | 16.69% | 19.10% | 18.30% | 18.43% | 19.22% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Chemed Corporation data
About Chemed Corporation (CHE) Income Statement
Chemed Corporation (CHE) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, CHE reported revenue of $2.53B, gross profit of $0.76B (gross margin 29.97%), and net income of $0.27B — a net profit margin of 10.48%.
Frequently asked questions
CHE · 4 questionsChemed Corporation (CHE) reported revenue of $2.53B for 2025, up 4.1% year-over-year.
CHE revenueCHE salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08